Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Top 100 Drugs

Top 200 by sales

Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon

Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone

Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec

More A-K · More L-Z · By Class · UK Medicines

For Consumers

For Professionals

For Researchers

Announcements

Physician's Desk Reference (PDR)

Latest FDA New Drug Approvals

Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an ...

Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic ...

Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell carcinoma (BCC).

More...

Drugs in Development – Not yet approved

lorcaserin
Lorcaserin is a selective serotonin 2C receptor agonist in development for weight management, including weight loss and maintenance of ...

Gattex
Gattex (teduglutide) is a novel, recombinant analog of human glucagon-like peptide 2 in development for the treatment of adults with short ...

bosutinib
Bosutinib is an oral, once-daily, investigational dual Src and Abl kinase inhibitor in development for the treatment of Philadelphia ...

More...

Daily Medical News

RSS

More Americans Seeking Love Online: Study

MONDAY, Feb. 6 -- Online dating has upended traditional matchmaking, new research suggests, with more would-be suitors embracing the notion that Mr. or Ms. Right may only be a click away. A review of roughly 400 studies and surveys reveals that for an estimated 25 million users around the world, the online dating scene has gone mainstream, shedding all vestiges of stigma. Online dating is now...

Fewer Teens Exposed to Tobacco Smoke in Cars: Report

MONDAY, Feb. 6 -- Although fewer kids are being exposed to smoking while riding in cars, more than 20 percent of nonsmoking teens still are, U.S. health officials report. Secondhand smoke can be particularly intense in a closed space, such as inside a car, and poses a significant health risk, the researchers noted. "There have been marked decreases in exposure to smoking in cars," said report...

Thousands of U.S. Kids Hospitalized for Abuse

MONDAY, Feb. 6 -- Close to 4,600 kids in the United States were hospitalized as a result of child abuse in one recent year, and 300 of them died, a new study shows. Researchers from Yale University analyzed information from the 2006 Kids' Inpatient Database to determine the rate of hospitalizations due to serious physical abuse among children under the age of 18. Infants aged 1 year or younger...

More...

Latest Pharma Industry News

RSS

FDA Approves Jentadueto (linagliptin/metformin hydrochloride) for the Treatment of Adult Patients with Type 2 Diabetes

RIDGEFIELD, Conn., and INDIANAPOLIS, Jan. 30, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin. Jentadueto provides a...

FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer

The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today’s action also highlights an increase in overall patient survival when the drug is taken for 36 months rather than the standard 12 months of treatment. Gleevec was originally granted...

Cegedim Strategic Data (CSD) Tracks Pharmaceutical Companies' Print Advertising Investments

Rate of Decline in Print Advertising Investments Slows to 4% for 12 Months Ending September 2011 Across Ten Key Markets PARIS--(Marketwire - Feb 6, 2012) - Cegedim Strategic Data (CSD) (www.cegedimstrategicdata.com), leading provider of integrated healthcare market research and worldwide promotional audits, has released audited marketing figures on pharmaceutical companies' print advertising...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Jentadueto, Kalydeco, Voraxaze, Erivedge, Bydureon, Inlyta, Picato, Zetonna, Subsys, Edarbyclor ...also see new filings.

Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch

Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...

Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store

1st June, 2011 – We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more ...

Pill Identifier Update

We’ve updated our pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest an ...

See more blog posts or follow us on twitter.

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search: